US Stock MarketDetailed Quotes
BLFS BioLife Solutions
- 26.010
- +0.620+2.44%
Close Nov 22 16:00 ET
- 26.010
- 0.0000.00%
Post 20:01 ET
1.21BMarket Cap-23432P/E (TTM)
26.060High25.100Low585.68KVolume25.730Open25.390Pre Close15.07MTurnover1.62%Turnover RatioLossP/E (Static)46.39MShares28.88052wk High3.71P/B941.30MFloat Cap11.91052wk Low--Dividend TTM36.19MShs Float72.188Historical High--Div YieldTTM3.78%Amplitude0.140Historical Low25.727Avg Price1Lot Size
BioLife Solutions Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 29.69%30.57M | -3.11%28.33M | -15.85%31.73M | -11.43%143.27M | 38.46%61.28M | -42.15%23.57M | -27.87%29.24M | 4.09%37.7M | 35.75%161.76M | 18.64%44.26M |
| Operating revenue | 29.69%30.57M | -3.11%28.33M | -15.85%31.73M | -11.43%143.27M | 38.46%61.28M | -42.15%23.57M | -27.87%29.24M | 4.09%37.7M | 35.75%161.76M | 18.64%44.26M |
| Cost of revenue | 23.30%14.28M | -26.23%13.44M | -19.01%19.17M | -10.58%96.52M | 70.13%51.53M | -57.13%11.58M | -30.47%18.21M | -3.20%23.66M | 31.46%107.94M | -2.74%30.29M |
| Gross profit | 35.85%16.3M | 35.10%14.89M | -10.53%12.56M | -13.14%46.75M | -30.22%9.75M | -12.69%12M | -23.12%11.02M | 19.24%14.04M | 45.28%53.82M | 126.62%13.97M |
| Operating expense | -13.92%17.85M | -21.63%17.69M | -16.61%22.45M | 11.26%104.29M | 61.71%39.08M | -10.34%20.74M | -3.37%22.57M | 16.73%26.92M | 38.46%93.74M | 5.89%24.17M |
| Selling and administrative expenses | -5.07%14.89M | -17.13%14.4M | -15.53%18M | 15.98%80.31M | 61.85%30.01M | -8.75%15.69M | 1.78%17.37M | 29.79%21.31M | 45.24%69.24M | 13.14%18.54M |
| -Selling and marketing expense | -27.34%3.54M | -8.59%3.5M | -21.65%5.07M | 13.97%24.58M | 98.56%11.85M | -7.62%4.88M | -29.25%3.83M | 32.30%6.47M | 54.01%21.57M | 24.93%5.97M |
| -General and administrative expense | 4.98%11.35M | -19.54%10.89M | -12.86%12.93M | 16.90%55.73M | 44.42%18.16M | -9.26%10.81M | 16.20%13.54M | 28.73%14.84M | 41.59%47.67M | 8.29%12.57M |
| Research and development costs | -45.17%2.05M | -37.20%2.38M | -14.88%3.53M | 27.02%18.8M | 92.70%8.02M | 9.17%3.74M | 10.65%3.79M | 9.81%4.15M | 25.18%14.8M | 16.61%4.16M |
| Depreciation amortization depletion | -30.64%910K | -35.28%910K | -37.35%914K | -46.57%5.18M | -28.41%1.05M | -47.79%1.31M | -50.89%1.41M | -49.04%1.46M | 18.23%9.7M | -48.95%1.46M |
| -Depreciation and amortization | -30.64%910K | -35.28%910K | -37.35%914K | -46.57%5.18M | -28.41%1.05M | -47.79%1.31M | -50.89%1.41M | -49.04%1.46M | 18.23%9.7M | -48.95%1.46M |
| Operating profit | 82.17%-1.56M | 75.79%-2.8M | 23.24%-9.89M | -44.15%-57.53M | -187.69%-29.33M | 6.91%-8.75M | -28.02%-11.55M | -14.12%-12.89M | -30.23%-39.91M | 38.79%-10.2M |
| Net non-operating interest income expense | 40.53%-267K | 6.72%-361K | 49.64%-207K | -163.76%-1.81M | -36.38%-596K | -2,893.33%-449K | -1,109.38%-387K | -123.37%-411K | -41.65%-687K | -183.77%-437K |
| Non-operating interest expense | -40.53%267K | -6.72%361K | -49.64%207K | ---- | ---- | 2,893.33%449K | 1,109.38%387K | 123.37%411K | ---- | ---- |
| Total other finance cost | ---- | ---- | ---- | 163.76%1.81M | ---- | ---- | ---- | ---- | 41.65%687K | ---- |
| Other net income (expense) | 101.46%95K | -162.18%-3.99M | 102.45%8K | 93.37%-6.91M | 83.18%-6.5M | -330.99%-6.5M | 109.50%6.42M | -109.44%-326K | -5,044.35%-104.23M | -2,454.00%-38.64M |
| Gain on sale of security | ---- | ---4.07M | ---- | ---- | ---- | ---- | ---- | ---- | 676.03%697K | --0 |
| Special income (charges) | --0 | --0 | 67.08%-237K | 92.26%-8.18M | 82.70%-6.76M | -186.87%-6.73M | 108.93%6.03M | -121.66%-720K | -5,544.74%-105.63M | -2,060.09%-39.08M |
| -Less：Restructuring and merger&acquisition | --0 | --0 | -67.08%237K | -54.31%-7.31M | 70.10%-415K | -167.35%-1.58M | -156.07%-6.03M | 121.66%720K | -144.12%-4.74M | -176.73%-1.39M |
| -Less:Impairment of capital assets | --0 | ---- | ---- | -85.97%15.49M | -82.27%7.18M | --8.31M | ---- | ---- | --110.36M | --40.46M |
| Other non- operating income (expenses) | -59.57%95K | -78.13%84K | -37.82%245K | 79.55%1.26M | -39.63%262K | 65.49%235K | 1,845.45%384K | 200.76%394K | 143.60%704K | 46.62%434K |
| Income before tax | 88.97%-1.73M | -29.55%-7.15M | 25.93%-10.09M | 54.25%-66.26M | 26.08%-36.42M | -43.72%-15.69M | 92.80%-5.52M | -69.85%-13.62M | -398.96%-144.83M | -168.92%-49.27M |
| Income tax | -124.35%-28K | 0 | 42.39%131K | 103.37%169K | 52.94%-40K | 119.20%115K | 100.05%2K | 115.36%92K | 75.04%-5.02M | 96.70%-85K |
| Net income | 94.15%-1.7M | -103.15%-20.72M | 25.47%-10.22M | 52.49%-66.43M | 72.79%-13.38M | -182.37%-29.13M | 86.01%-10.2M | -84.80%-13.71M | -1,469.43%-139.81M | -212.41%-49.19M |
| Net income continuous Operations | 89.22%-1.7M | -29.50%-7.15M | 25.47%-10.22M | 52.49%-66.43M | 26.03%-36.38M | -53.18%-15.8M | 92.43%-5.52M | -84.80%-13.71M | -1,469.43%-139.81M | -212.41%-49.19M |
| Net income discontinuous operations | --0 | -189.96%-13.57M | ---- | ---- | ---- | ---13.33M | ---4.68M | ---- | ---- | ---- |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 94.15%-1.7M | -103.15%-20.72M | 25.47%-10.22M | 52.49%-66.43M | 72.79%-13.38M | -182.37%-29.13M | 86.01%-10.2M | -84.80%-13.71M | -1,469.43%-139.81M | -212.41%-49.19M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 94.15%-1.7M | -103.15%-20.72M | 25.47%-10.22M | 52.49%-66.43M | 72.79%-13.38M | -182.37%-29.13M | 86.01%-10.2M | -84.80%-13.71M | -1,469.43%-139.81M | -216.76%-49.19M |
| Basic earnings per share | 94.03%-0.04 | -95.65%-0.45 | 31.25%-0.22 | 53.80%-1.52 | 73.91%-0.3 | -179.17%-0.67 | 86.63%-0.23 | -77.78%-0.32 | -1,330.43%-3.29 | -210.81%-1.15 |
| Diluted earnings per share | 94.03%-0.04 | -95.65%-0.45 | 31.25%-0.22 | 53.80%-1.52 | 73.91%-0.3 | -179.17%-0.67 | 86.63%-0.23 | -77.78%-0.32 | -1,330.43%-3.29 | -210.81%-1.15 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data